Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 54 for

Edit search filters
  1. Transforming Non-Invasive Liver Disease Detection by Magnetic Resonance Elastography

    Rochester, MN

  2. A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia

    Scottsdale/Phoenix, AZ

  3. A Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 with Terlipressin Treatment

    Scottsdale/Phoenix, AZ

  4. Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis

    Scottsdale/Phoenix, AZ

  5. A Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients with Primary Biliary Cirrhosis

    Rochester, MN

  6. Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH

    Scottsdale/Phoenix, AZ

  7. Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites

    Scottsdale/Phoenix, AZ

  8. Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

    Scottsdale/Phoenix, AZ

  10. A Study of Improving Liver Ultrasound Effectiveness for Fibrosis Staging

    Rochester, MN

.

Mayo Clinic Footer